Systemic PCP treatment elevates brain extracellular 5-HT: A microdialysis study in awake rats

NeuroReport

Volumn 9, Issue 13, 1998, Pages 2985-2988

  Martin, Peter ^a   Carlsson, Maria L ^a   Hjorth, Stephan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

GABA; Microdialysis; NMDA receptor antagonist; Phencyclidine; Rat; Schizophrenia; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; CITALOPRAM; PHENCYCLIDINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE;

EID: 0032517108     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199809140-00012     Document Type: Article

References (27)

1. Bunney BG, Bunney WE, Carlsson A. Schizophrenia and Glutamate. In: Bloom FE and Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York; Raven Press, 1995: 1205-1214.
2. Anis NA, Berry SC, Burton NR et al. Br J Pharmacol 79, 565-575 (1983).
3. Carboni E, Imperato A, Perezzani L et al. Neuroscience 28, 653-661 (1989).
4. Hondo H, Yonezawa Y, Nakahara T et al. Brain Res 633, 337-342 (1994).
5. Hernandez L, Auerhach S and Hoebel BG. Life Sci 42, 1713-1723 (1988).
6. Smith RC, Meltzer HY, Arora RC et al. Biochem Pharmacol 26, 1435-1439 (1977).
7. Hori T, Suzuki T, Baba A et al. Neurosci Lett 209, 153-156 (1996).
8. Arora RC and Meltzer HY. Life Sci 27, 1607-1613 (1980)
9. Javitt DC and Zukin SR. Am J Psychiatry 148, 1301-1308 (1991).
10. Tonge SR and Leonard BE. J Pharm Pharmacol 23, 711 (1971).
11. Nabeshima T, Yamaguchi K, Hiramatsu M et al. Pharmacol Biochem Behav 21, 401-408 (1984).
12. Nabeshima T, Hiramatsu M, Furukawa H et al. Life Sci 36, 939-946 (1985).
13. Martin P, Waters N, Schmidt CJ et al. J Neural Transm, in press (1998).
14. Lillrank SM, O'Connor WT, Oja SS et al. J Neural Transm [Gen Sect] 95, 145-155 (1994).
15. Crespi F and Keane PE. Pharmacol Res Commun 19, 639-649 (1987).
16. Waters N, Lagerkvist S, Löfberg L et al. Eur J Pharmacol 242, 151-163 (1993).
17. Hjorth S and Sharp T. J Pharmacol Exp Ther 265, 707-712 (1993).
18. McQuade R. Thesis. Depts of Clin Pharmacology and Psychiatry, Wadham College, Univ of Oxford (1996).
19. Invernizzi R, Velasco C, Bramante M et al. Neuropharmacology 36, 467-473 (1997).
20. Hjorth S and Auerbach SB. Eur J Pharmacol 260, 251-255 (1994).
21. Auerbach SB, Lunberg JF and Hjorth S. Neuropharmacology 34, 89-96 (1995).
22. Carboni E and Di Chiara G. Neurosci 32, 637-645 (1989).
23. Hondo H, Nakahara T, Nakamura K et al. Brain Res 671, 54-62 (1995).
24. Yan Q-S, Reith MEA, Jobe PC et al. Brain Res 765, 149-158 (1997).
25. Whitton PS, Biggs CS and Pearce BR. J Neurochem 58, 1573-1575 (1992).
26. Hiramatsu M, Cho AK and Nabeshima T. Eur J Pharmacol 166, 359-366 (1989).
27. Lejeune F, Gobert A, Rivet J M et al. Brain Res 656, 427-431 (1994).